The Next Chapter In Treating Alzheimer’s
It’s not often that drug company executives will sing the praises of a competitor’s drug. But at a recent neuroscience forum in Boston, nearly every suit on the dais had good things to say about aducanumab, an Alzheimer’s disease treatment being developed by Biogen.
Vote:
0
